Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Adult adipose-derived stem cells and breast cancer: a controversial relationship.

SpringerPlus

Bielli A, Scioli MG, Gentile P, Agostinelli S, Tarquini C, Cervelli V, Orlandi A.
PMID: 25089245
Springerplus. 2014 Jul 08;3:345. doi: 10.1186/2193-1801-3-345. eCollection 2014.

Breast cancer is the most common cancer in women and autologous fat grafting is an important clinical application in treatment of post-surgical deformities. The simplicity of fat grafting procedures and the absence of subsequent visible scar prompted an increasing...

Cite
Bielli A, Scioli MG, Gentile P, et al. Adult adipose-derived stem cells and breast cancer: a controversial relationship. Springerplus. 2014;3:345doi: 10.1186/2193-1801-3-345.
Bielli, A., Scioli, M. G., Gentile, P., Agostinelli, S., Tarquini, C., Cervelli, V., & Orlandi, A. (2014). Adult adipose-derived stem cells and breast cancer: a controversial relationship. SpringerPlus, 3345. https://doi.org/10.1186/2193-1801-3-345
Bielli, Alessandra, et al. "Adult adipose-derived stem cells and breast cancer: a controversial relationship." SpringerPlus vol. 3 (2014): 345. doi: https://doi.org/10.1186/2193-1801-3-345
Bielli A, Scioli MG, Gentile P, Agostinelli S, Tarquini C, Cervelli V, Orlandi A. Adult adipose-derived stem cells and breast cancer: a controversial relationship. Springerplus. 2014 Jul 08;3:345. doi: 10.1186/2193-1801-3-345. eCollection 2014. PMID: 25089245; PMCID: PMC4117859.
Copy Download .nbib Format: NLM
Enteropathogen Changes After Rotavirus Vaccine Scale-up.

Pediatrics

Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH.
PMID: 34918158
Pediatrics. 2022 Jan 01;149(1). doi: 10.1542/peds.2020-049884.

OBJECTIVES: To inform next steps in pediatric diarrhea burden reduction by understanding the shifting enteropathogen landscape after rotavirus vaccine implementation.METHODS: We conducted a case-control study of 1788 medically attended children younger than 5 years, with and without gastroenteritis, after...

Cite
Ballard SB, Requena D, Mayta H, et al. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2022;149(1)doi: 10.1542/peds.2020-049884.
Ballard, S. B., Requena, D., Mayta, H., Sanchez, G. J., Oyola-Lozada, M. G., Colquechagua Aliaga, F. D., Cabrera, L., Vittet Mondonedo, M. D., Taquiri, C., Tilley, C. D. H., Simons, C. M. P., Meza, R. A., Bern, C., Saito, M., Figueroa-Quintanilla, D. A., & Gilman, R. H. (2022). Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics, 149(1), . https://doi.org/10.1542/peds.2020-049884
Ballard, Sarah-Blythe, et al. "Enteropathogen Changes After Rotavirus Vaccine Scale-up." Pediatrics vol. 149,1 (2022). doi: https://doi.org/10.1542/peds.2020-049884
Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2022 Jan 01;149(1). doi: 10.1542/peds.2020-049884. PMID: 34918158.
Copy Download .nbib Format: NLM
Enteropathogen Changes After Rotavirus Vaccine Scale-up.

Pediatrics

Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH.
PMID: 34918158
Pediatrics. 2021 Dec 17; doi: 10.1542/peds.2020-049884. Epub 2021 Dec 17.

OBJECTIVES: To inform next steps in pediatric diarrhea burden reduction by understanding the shifting enteropathogen landscape after rotavirus vaccine implementation.METHODS: We conducted a case-control study of 1788 medically attended children younger than 5 years, with and without gastroenteritis, after...

Cite
Ballard SB, Requena D, Mayta H, et al. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2021;doi: 10.1542/peds.2020-049884.
Ballard, S. B., Requena, D., Mayta, H., Sanchez, G. J., Oyola-Lozada, M. G., Colquechagua Aliaga, F. D., Cabrera, L., Vittet Mondonedo, M. D., Taquiri, C., Tilley, C. D. H., Simons, C. M. P., Meza, R. A., Bern, C., Saito, M., Figueroa-Quintanilla, D. A., & Gilman, R. H. (2021). Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics, . https://doi.org/10.1542/peds.2020-049884
Ballard, Sarah-Blythe, et al. "Enteropathogen Changes After Rotavirus Vaccine Scale-up." Pediatrics vol. (2021). doi: https://doi.org/10.1542/peds.2020-049884
Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2021 Dec 17; doi: 10.1542/peds.2020-049884. Epub 2021 Dec 17. PMID: 34918158.
Copy Download .nbib Format: NLM
[Considerations on the peripheral and precordial rheogram in congenital cardiopathies].

Minerva cardioangiologica

MORASSUTTI MP, NATTERO G, TARQUINI A.
PMID: 14423976
Minerva Cardioangiol. 1959 Oct;7:532-9.

No abstract available.

Cite
MORASSUTTI MP, NATTERO G, TARQUINI A. [Considerations on the peripheral and precordial rheogram in congenital cardiopathies]. Minerva Cardioangiol. 1959;7:532-9
MORASSUTTI, M. P., NATTERO, G., & TARQUINI, A. (1959). [Considerations on the peripheral and precordial rheogram in congenital cardiopathies]. Minerva cardioangiologica, 7532-9.
MORASSUTTI, M P, et al. "[Considerations on the peripheral and precordial rheogram in congenital cardiopathies]." Minerva cardioangiologica vol. 7 (1959): 532-9.
MORASSUTTI MP, NATTERO G, TARQUINI A. [Considerations on the peripheral and precordial rheogram in congenital cardiopathies]. Minerva Cardioangiol. 1959 Oct;7:532-9. Italian. PMID: 14423976.
Copy Download .nbib Format: NLM
Expression and potential role of cellular retinol binding protein I in psoriasis.

Oncotarget

Costanza G, Doldo E, Ferlosio A, Tarquini C, Passeri D, Cascella R, Bavetta M, Di Stefani A, Bonifati C, Agostinelli S, Centofanti F, Giardina E, Campione E, Bianchi L, Donati P, Morrone A, Orlandi A.
PMID: 30613363
Oncotarget. 2018 Dec 04;9(95):36736-36749. doi: 10.18632/oncotarget.26314. eCollection 2018 Dec 04.

Psoriasis is a diffuse chronic skin disorder characterized from accelerated epidermal turnover and inflammatory cell infiltrate. Retinoids influence keratinocyte proliferation and differentiation as well as inflammatory response. Cellular retinol binding protein (CRBPI) regulates intracellular vitamin A bioavailability and contributes...

Cite
Costanza G, Doldo E, Ferlosio A, et al. Expression and potential role of cellular retinol binding protein I in psoriasis. Oncotarget. 2018;9(95):36736-36749doi: 10.18632/oncotarget.26314.
Costanza, G., Doldo, E., Ferlosio, A., Tarquini, C., Passeri, D., Cascella, R., Bavetta, M., Di Stefani, A., Bonifati, C., Agostinelli, S., Centofanti, F., Giardina, E., Campione, E., Bianchi, L., Donati, P., Morrone, A., & Orlandi, A. (2018). Expression and potential role of cellular retinol binding protein I in psoriasis. Oncotarget, 9(95), 36736-36749. https://doi.org/10.18632/oncotarget.26314
Costanza, Gaetana, et al. "Expression and potential role of cellular retinol binding protein I in psoriasis." Oncotarget vol. 9,95 (2018): 36736-36749. doi: https://doi.org/10.18632/oncotarget.26314
Costanza G, Doldo E, Ferlosio A, Tarquini C, Passeri D, Cascella R, Bavetta M, Di Stefani A, Bonifati C, Agostinelli S, Centofanti F, Giardina E, Campione E, Bianchi L, Donati P, Morrone A, Orlandi A. Expression and potential role of cellular retinol binding protein I in psoriasis. Oncotarget. 2018 Dec 04;9(95):36736-36749. doi: 10.18632/oncotarget.26314. eCollection 2018 Dec 04. PMID: 30613363; PMCID: PMC6298411.
Copy Download .nbib Format: NLM
Chronic pulmonary heart with and without heart failure; respiratory and circulatory functions.

Medicina

TAQUINI AC, LOZADA BB.
PMID: 18102065
Medicina (B Aires). 1948 Aug;8(4):325-35.

No abstract available.

Cite
TAQUINI AC, LOZADA BB. Corazón pulmonar crónico con y sin insuficiencia cardiaca; funciones respiratoria y circulatoria. Chronic pulmonary heart with and without heart failure; respiratory and circulatory functions. Medicina (B Aires). 1948;8(4):325-35
TAQUINI, A. C., & LOZADA, B. B. (1948). Corazón pulmonar crónico con y sin insuficiencia cardiaca; funciones respiratoria y circulatoria. Chronic pulmonary heart with and without heart failure; respiratory and circulatory functions. Medicina, 8(4), 325-35.
TAQUINI, A C, and LOZADA, B B. "Corazón pulmonar crónico con y sin insuficiencia cardiaca; funciones respiratoria y circulatoria." Chronic pulmonary heart with and without heart failure; respiratory and circulatory functions. Medicina vol. 8,4 (1948): 325-35.
TAQUINI AC, LOZADA BB. Corazón pulmonar crónico con y sin insuficiencia cardiaca; funciones respiratoria y circulatoria. Chronic pulmonary heart with and without heart failure; respiratory and circulatory functions. Medicina (B Aires). 1948 Aug;8(4):325-35. Spanish. PMID: 18102065.
Copy Download .nbib Format: NLM
[Evolutionary arterial hypertension].

Arquivos brasileiros de cardiologia

TAQUINI AC.
PMID: 13651014
Arq Bras Cardiol. 1959 Mar;12(1):51-6.

No abstract available.

Cite
TAQUINI AC. Hipertensión arterial evolutiva. [Evolutionary arterial hypertension]. Arq Bras Cardiol. 1959;12(1):51-6
TAQUINI, A. C. (1959). Hipertensión arterial evolutiva. [Evolutionary arterial hypertension]. Arquivos brasileiros de cardiologia, 12(1), 51-6.
TAQUINI, A C. "Hipertensión arterial evolutiva." [Evolutionary arterial hypertension]. Arquivos brasileiros de cardiologia vol. 12,1 (1959): 51-6.
TAQUINI AC. Hipertensión arterial evolutiva. [Evolutionary arterial hypertension]. Arq Bras Cardiol. 1959 Mar;12(1):51-6. Portuguese. PMID: 13651014.
Copy Download .nbib Format: NLM
Enteropathogen Changes After Rotavirus Vaccine Scale-up.

Pediatrics

Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH.
PMID: 34918158
Pediatrics. 2022 Jan 01;149(1). doi: 10.1542/peds.2020-049884.

OBJECTIVES: To inform next steps in pediatric diarrhea burden reduction by understanding the shifting enteropathogen landscape after rotavirus vaccine implementation.METHODS: We conducted a case-control study of 1788 medically attended children younger than 5 years, with and without gastroenteritis, after...

Cite
Ballard SB, Requena D, Mayta H, et al. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2022;149(1)doi: 10.1542/peds.2020-049884.
Ballard, S. B., Requena, D., Mayta, H., Sanchez, G. J., Oyola-Lozada, M. G., Colquechagua Aliaga, F. D., Cabrera, L., Vittet Mondonedo, M. D., Taquiri, C., Tilley, C. D. H., Simons, C. M. P., Meza, R. A., Bern, C., Saito, M., Figueroa-Quintanilla, D. A., & Gilman, R. H. (2022). Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics, 149(1), . https://doi.org/10.1542/peds.2020-049884
Ballard, Sarah-Blythe, et al. "Enteropathogen Changes After Rotavirus Vaccine Scale-up." Pediatrics vol. 149,1 (2022). doi: https://doi.org/10.1542/peds.2020-049884
Ballard SB, Requena D, Mayta H, Sanchez GJ, Oyola-Lozada MG, Colquechagua Aliaga FD, Cabrera L, Vittet Mondonedo MD, Taquiri C, Tilley CDH, Simons CMP, Meza RA, Bern C, Saito M, Figueroa-Quintanilla DA, Gilman RH. Enteropathogen Changes After Rotavirus Vaccine Scale-up. Pediatrics. 2022 Jan 01;149(1). doi: 10.1542/peds.2020-049884. PMID: 34918158.
Copy Download .nbib Format: NLM
FAGARINE, A POSSIBLE SUBSTITUTE FOR QUINIDINE.

Science (New York, N.Y.)

Deulofeu V, Labriola R, Orías O, DE Espanés EM, Taquini A.
PMID: 17821284
Science. 1945 Jul 20;102(2638):69-70. doi: 10.1126/science.102.2638.69.

No abstract available.

Cite
Deulofeu V, Labriola R, Orías O, et al. FAGARINE, A POSSIBLE SUBSTITUTE FOR QUINIDINE. Science. 1945;102(2638):69-70doi: 10.1126/science.102.2638.69.
Deulofeu, V., Labriola, R., Orías, O., DE Espanés, E. M., & Taquini, A. (1945). FAGARINE, A POSSIBLE SUBSTITUTE FOR QUINIDINE. Science (New York, N.Y.), 102(2638), 69-70. https://doi.org/10.1126/science.102.2638.69
Deulofeu, V, et al. "FAGARINE, A POSSIBLE SUBSTITUTE FOR QUINIDINE." Science (New York, N.Y.) vol. 102,2638 (1945): 69-70. doi: https://doi.org/10.1126/science.102.2638.69
Deulofeu V, Labriola R, Orías O, DE Espanés EM, Taquini A. FAGARINE, A POSSIBLE SUBSTITUTE FOR QUINIDINE. Science. 1945 Jul 20;102(2638):69-70. doi: 10.1126/science.102.2638.69. PMID: 17821284.
Copy Download .nbib Format: NLM
[Oscar Orias].

Medicina

TAQUINI AC.
PMID: 13264926
Medicina (B Aires). 1955 Jun;15(3):141-3.

No abstract available.

Cite
TAQUINI AC. Oscar Orias. [Oscar Orias]. Medicina (B Aires). 1955;15(3):141-3
TAQUINI, A. C. (1955). Oscar Orias. [Oscar Orias]. Medicina, 15(3), 141-3.
TAQUINI, A C. "Oscar Orias." [Oscar Orias]. Medicina vol. 15,3 (1955): 141-3.
TAQUINI AC. Oscar Orias. [Oscar Orias]. Medicina (B Aires). 1955 Jun;15(3):141-3. Spanish. PMID: 13264926.
Copy Download .nbib Format: NLM
[Treatment of arterial hypertension].

El Dia medico

PADILLA T, TAQUINI A, DIEZ J, INTROZZI AS, ETCHEVES JC, BENAROS M.
PMID: 14380016
Dia Med. 1955 Apr 07;27(20):513-22.

No abstract available.

Cite
PADILLA T, TAQUINI A, DIEZ J, et al. Tratamiento de la hipertensión arterial. [Treatment of arterial hypertension]. Dia Med. 1955;27(20):513-22
PADILLA, T., TAQUINI, A., DIEZ, J., INTROZZI, A. S., ETCHEVES, J. C., & BENAROS, M. (1955). Tratamiento de la hipertensión arterial. [Treatment of arterial hypertension]. El Dia medico, 27(20), 513-22.
PADILLA, T, et al. "Tratamiento de la hipertensión arterial." [Treatment of arterial hypertension]. El Dia medico vol. 27,20 (1955): 513-22.
PADILLA T, TAQUINI A, DIEZ J, INTROZZI AS, ETCHEVES JC, BENAROS M. Tratamiento de la hipertensión arterial. [Treatment of arterial hypertension]. Dia Med. 1955 Apr 07;27(20):513-22. Spanish. PMID: 14380016.
Copy Download .nbib Format: NLM
The blood-pressure raising secretion of the ischaemic kidney.

The Journal of physiology

Fasciolo JC, Houssay BA, Taquini AC.
PMID: 16995044
J Physiol. 1938 Dec 14;94(3):281-93. doi: 10.1113/jphysiol.1938.sp003680.

No abstract available.

Cite
Fasciolo JC, Houssay BA, Taquini AC. The blood-pressure raising secretion of the ischaemic kidney. J Physiol. 1938;94(3):281-93doi: 10.1113/jphysiol.1938.sp003680.
Fasciolo, J. C., Houssay, B. A., & Taquini, A. C. (1938). The blood-pressure raising secretion of the ischaemic kidney. The Journal of physiology, 94(3), 281-93. https://doi.org/10.1113/jphysiol.1938.sp003680
Fasciolo, J C, et al. "The blood-pressure raising secretion of the ischaemic kidney." The Journal of physiology vol. 94,3 (1938): 281-93. doi: https://doi.org/10.1113/jphysiol.1938.sp003680
Fasciolo JC, Houssay BA, Taquini AC. The blood-pressure raising secretion of the ischaemic kidney. J Physiol. 1938 Dec 14;94(3):281-93. doi: 10.1113/jphysiol.1938.sp003680. PMID: 16995044; PMCID: PMC1393762.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries